Abstract:Abstract Background Lung transplant patients (LTPs) experience considerable infection-related morbidity and mortality, including from pneumonia. Our institution performs the highest volume of lung transplants in the US, providing an opportunity to describe the scope and impact of pneumonia in LTPs. Methods We conducted a retrospective cohort study of all patients who received a lung transplant at our institution from late 2017 to early 2020. Patient records were reviewed from the pre-transplant period to 1-year after transplant for data pertinent to comorbidities, transplantation characteristics and complications, donor organ cultures, immunosuppression, prophylactic and therapeutic antibiotic regimens, pathogens, and outcomes. Cases of pneumonia were reviewed using standard criteria. The primary outcome was 1-year survival. Results 320 patients received lung transplants and 121(38%) developed pneumonia. Characteristics are in Table 1. Pneumonia developed a median of 66 days after transplant (IQR 15-142). Most frequent pathogens ( >10 cases) were P. aeruginosa, S. aureus, and K. pneumoniae. The most common viral cause was RSV (5 cases). Patients with pneumonia had significantly lower 1-year survival rates than those without (100/120, 83.3% vs 186/199, 93.5%; p=0.004). Number of readmissions were higher in patients who had pneumonia (mean 3 ± 2.58 vs 2.04 + 3.18, p< 0.001). Bronchial stents (p< 0.001), past medical history of atrial fibrillation (0.003), and donor lung culture positive for E. coli (0.007) were independent risk factors for the development of pneumonia. Prophylaxis with piperacillin/tazobactam (0.032) prophylaxis with ciprofloxacin (0.008) were protective. Conclusion Pneumonia occurred within the first year of transplant in 38% of LTPs and was associated with lower survival. Disclosures Jason C. Gallagher, PharmD, Merck: Advisor/Consultant|Merck: Grant/Research Support|Qpex: Advisor/Consultant|Shionogi: Advisor/Consultant|Spero: Advisor/Consultant.

Infectious Complications in Lung Transplant Recipients

Pulmonary complications of lung transplantation.

The changing landscape of infections in the lung transplant recipient

Opportunistic Infections Post-Lung Transplantation: Viral, Fungal, and Mycobacterial

SARS-CoV-2 Infection in Transplant-Related Biology: Where Do We Stand?

Pulmonary transplant complications: a radiologic review

Fungal infection in lung transplantation.

Immunopathology of lung transplantation: from infection to rejection and vice versa

COVID-19 in Lung Transplant Recipients: A Report on 10 Recent Cases

Fungal Infection and Prevention in Lung Transplant

Unraveling the spectrum of airway complications following lung transplantation: a comprehensive overview

2117. Outcomes and Risk Factors Associated with Development of Pneumonia in Lung Transplant Recipients in the Year After Transplant

Recent advances in understanding and managing infectious diseases in solid organ transplant recipients

Critical Care after Lung Transplantation

Ocular complications in patients with lung transplants

Infectious Disease Considerations in Chronic Graft-versus-Host Disease and Transplantation Survivors

The Double-Edged Sword of Immunosuppressive Therapy in Kidney Transplantation: A Rare Case Report of Pulmonary Mucormycosis Post-Transplant and Literature Review

Invasive fungal infections in liver transplantation.

Infection prophylaxis and management of viral infection

Complications and survival in COPD patients undergoing lung transplantation

Infection in Organ Transplantation